4//SEC Filing
Elvig Mark F 4
Accession 0001000229-18-000027
CIK 0001000229other
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 5:51 PM ET
Size
5.8 KB
Accession
0001000229-18-000027
Insider Transaction Report
Form 4
Elvig Mark F
VP, Counsel & Secretary
Transactions
- Award
Performance Shares
2018-02-13+2,600→ 2,600 totalExercise: $0.00→ Common Shares (2,600 underlying)
Footnotes (1)
- [F1]This award vests at the end of a three-year performance period that begins on January 1, 2018 and ends on the last NYSE trading day of December 2020 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. At the end of the Performance Period, 100% of the award will vest if the Company is in the top 75th percentile of Return On Invested Capital of the Bloomberg Peer Group as shown by data published by Bloomberg upon the close of the NYSE market on the last trading day of the Performance Period. If this criteria is not met, then no shares shall vest and the award shall be forfeited.
Documents
Issuer
CORE LABORATORIES N V
CIK 0001000229
Entity typeother
Related Parties
1- filerCIK 0001435153
Filing Metadata
- Form type
- 4
- Filed
- Feb 14, 7:00 PM ET
- Accepted
- Feb 15, 5:51 PM ET
- Size
- 5.8 KB